%PDF-1.4
%
1 0 obj
<>stream
application/pdf
10.1080/21645515.2019.1586040
Safety profile of the RTS,S/AS01 malaria vaccine in infants and children: additional data from a phase III randomized controlled trial in sub-Saharan Africa
Yolanda Guerra Mendoza
Elodie Garric
Amanda Leach
Marc Lievens
Opokua Ofori-Anyinam
Jean-Yves Pirçon
Jens-Ulrich Stegmann
Pascale Vandoolaeghe
Lucas Otieno
Walter Otieno
Seth Owusu-Agyei
Jahit Sacarlal
Nahya Salim Masoud
Hermann Sorgho
Marcel Tanner
Halidou Tinto
Innocent Valea
Ali Takadir Mtoro
Patricia Njuguna
Martina Oneko
Godfrey Allan Otieno
Kephas Otieno
Samwel Gesase
Mary J Hamel
Irving Hoffman
Seyram Kaali
Portia Kamthunzi
Peter Kremsner
Miguel Lanaspa
Bertrand Lell
John Lusingu
Anangisye Malabeja
Pedro Aide
Pauline Akoo
Daniel Ansong
Kwaku Poku Asante
James A Berkley
Samuel Adjei
Tsiri Agbenyega
Selidji Todagbe Agnandji
Lode Schuerman
Taylor & Francis
Human Vaccines & Immunotherapeutics, 2019. doi:10.1080/21645515.2019.1586040
(5–10): Malaria
RTS,S/AS01 vaccine
safety
meningitis
febrile convulsions
cerebral malaria
en
Journal
Human Vaccines & Immunotherapeutics
© 2019 GlaxoSmithKline Biologicals SA. Published with license by Taylor & Francis Group, LLC.
2164-5515
2164-554X
15
10
2386
2398
10.1080/21645515.2019.1586040
https://doi.org/10.1080/21645515.2019.1586040
VoR
application/pdfdoi:10.1080/21645515.2019.158604010.1080/21645515.2019.1586040https://doi.org/10.1080/21645515.2019.15860402019-04-23truewww.tandfonline.com10.1080/21645515.2019.1586040www.tandfonline.comtrue2019-04-2310.1080/21645515.2019.1586040
endstream
endobj
4 0 obj
<>stream
xZɎW- UՆ}-l}_/dȮd0${1.9/mYf\rv3(cq-[!O3'Ƌ[t{\d߿sn}nUJ^Jx36(&he{NJ,yתd"r1?f/WL:MkӏZ\\\\\\wۏtN׃87_D%)7-cTNBQ<}drf6)dZeVXAGX93IqV2syu"y
T~+_S~[3X[7kZk:W%t%wဏxvn7bTzTyHSwg}x1s]훋*J;@nu#C_=dr`{AVG>|K<9,w
RDR[|(% {:4"N{M.}qQHc<sK9ؤ7hq%xEp], "j&BvqsFUnkdtD\ G;hϒXD?R;1.}xbCj=g.m*-e&ׇٝ̓D ~ྦT,Ӹ]p
\{pkL5pɹ#|Hf/ PN,w20A/7A,0ӥ@0;gdƻP҈q9uCڦ7P06;֜)rߜ x4̾\2g}#(/+1C `fG0"*E+lQ _
a` vݖ&@֭O!8K59ŖS=Yջp/P$Zda퇆Ϝ*@X^c[ȍY>sre/Xe.3?g}d:)o
guOPOAd~O-hJjcCvԨ=CF&Q9)Bq)ߥ0@C2IːYi_u Z7suWxwT/K;gܾ~S9!1\g9*17|# T= GéCQrw@s`lқ9s9g`?,[X@!-Qyϡm֡OOe
V*䙖RO@FK}|Nc^*JOE̖a^FQRwcWJXsY:wbBIb=4\M>%h z hʊ VVjDs_0(
4:,HҠ
2O]2
(G̩Eo˞PZ|eKlpe̋żY%7E5I:vĆ@4zHOdZ@iӫT%vbCҙF1ۡ&dmX("$⹁&}ξCy4ڡvP?k#m,[9M9NKHJwpmM&p-H95bMG,9 EDXAz;gK3]Vd习
{`\cucT`JK)h<"5= BBÌIx^Afυ
z ,ւ,d3OR쭢ɵ--JQĹ.Vk/Aw|kr1 ǵ U]М!+q,!BEy.t
ag2!e+8HaA_A'@Ђヒ:,5%DvSa#Å頉R,bMq[,s8˲2Nn KE-fC:I,%$By`vH`Ō(e8q$5?$5Ȇ{m~kjC}<,V7 -cyC"U4)K@FQ<,*,h-K&݉KJÁ/QzsIE#WnɄQм^j?Gՠ#DZݎBN[1,43Yhd7F/;}F4%
KbMs!,-\ȱ(|k,uVڗ8؊$F(QbqRFJ:i^
S^eܕ7ʈ+&Kx+1mEhzEɒ[t܂cV$Ԗ}^:,f^NFy3 &oIc-´!D|Y3*T֪#0mg`Fl=/ȵEKY8-ĤgC%BmCvwnSҞXcʹR){ԳVY2XCs& Z(Lwz6u!_,Yr3--{=bmNdKa>ڞX8K*@QkU>w93i
_uo
yM|^R'2xRi<5|tɟO?٨8aV5f=@oMuQZ5hP3])݊$4 mJ6-H=]s94|/8熑hyux$;Tہې+EЎ(I6wWwKɗjoZ:}{]%ϑ﹇MٕM5))n,= ݷ {N"uKkgh^%?#k].v